Fresenius Medical Care AG (FMS) Return on Capital Employed (2009 - 2025)

Fresenius Medical Care AG (FMS) has reported Return on Capital Employed for 17 consecutive years, with 14.5% the latest figure, recorded in Q4 2025.

• In Q4 2025, Return on Capital Employed rose 332.0% year-over-year to 14.5%; the TTM figure through Dec 2025 stood at 14.5% (up 332.0% YoY), while the FY2025 annual figure was 7.41%, up 247.0% from the prior year.
• Return on Capital Employed came in at 14.5% for Q4 2025 at Fresenius Medical Care AG, up from 11.85% in the prior quarter.
• The five-year high for Return on Capital Employed was 44.07% in Q1 2021, with the low at 4.42% in Q3 2023.
• Average Return on Capital Employed over 5 years is 12.86%, with a median of 11.65% recorded in 2025.
• Across the five-year window, Return on Capital Employed soared 1705 bps in 2021 and plunged 2780 bps in 2022, its largest moves.
• Year by year, Return on Capital Employed stood at 18.77% in 2021, then plunged by 34 bps to 12.43% in 2022, then dropped by 24 bps to 9.46% in 2023, then increased by 18 bps to 11.18% in 2024, then climbed by 30 bps to 14.5% in 2025.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 14.5%, 11.85%, and 11.89% for Q4 2025, Q3 2025, and Q2 2025 respectively.